Joakim Nordanstig

机构：Sahlgrenska University Hospital, University of Gothenburg · ORCID：0000-0002-2670-2268

发表论文 168 篇 · 总被引 4205 次 · h-index 33

代表论文

Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial (2025 · The Lancet · 被引 157)
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in patients with intermittent claudication (SWEDEPAD 2): a multicentre, participant-masked, registry-based, randomised controlled trial (2025 · The Lancet · 被引 55)
Paclitaxel-coated versus uncoated devices for infrainguinal endovascular revascularisation in chronic limb-threatening ischaemia (SWEDEPAD 1): a multicentre, participant-masked, registry-based, randomised controlled trial (2025 · The Lancet · 被引 40)
Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes (2024 · European Heart Journal - Cardiovascular Pharmacotherapy · 被引 24)
Benefit of Semaglutide in Symptomatic Peripheral Artery Disease by Baseline Type 2 Diabetes Characteristics: Insights From STRIDE, a Randomized, Placebo-Controlled, Double-Blind Trial (2025 · Diabetes Care · 被引 14)
Management of Peripheral Artery Disease in Adults With Diabetes: 2025 ACC Scientific Statement (2025 · Journal of the American College of Cardiology · 被引 10)